A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations

Recruiting

Phase 3

Fluticasone/AlbuterolA Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations

Sponsor:

Teva Branded Pharmaceutical Products R&D, Inc.

Code:

NCT06052267

Conditions

Asthma

Eligibility Criteria

Sex: All

Age: 4+

Healthy Volunteers: Not accepted

Interventions

TEV-56248

Albuterol sulfate

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-11-07. This information was provided to ClinicalTrials.gov by Teva Branded Pharmaceutical Products R&D, Inc. on 2025-10-23.